Guardant Health, INC Form 4 insider transactions

AmirAli Talasaz, Co-Chief Executive Officer and Director of Guardant Health, Inc., reported transactions involving common stock and restricted stock units.

Guardant Health Director Steve Krognes acquired 155 shares of common stock through the vesting of restricted stock units.

Guardant Health's Chief Information Officer, Kumud Kalia, has paid $192 to the company to settle recoverable Section 16(b) short-swing profits from recent stock transactions.

AmirAli Talasaz, Co-Chief Executive Officer and Director of Guardant Health, Inc., reported transactions involving the sale of common stock and acquisition of stock options.

Chief Information Officer Kumud Kalia acquired 638 shares of Guardant Health common stock via RSU vesting, with 314 shares withheld for taxes.

Director Tariq Musa reported the vesting of restricted stock units and a subsequent sale of Guardant Health common stock.

Chief Legal Officer John G. Saia acquired 1,020 shares of Guardant Health common stock via RSU vesting, with 535 shares withheld for taxes.

Chief Commercial Officer Chris Freeman acquired 1,402 shares of Guardant Health common stock via restricted stock unit vesting.

Guardant Health CFO Michael Brian Bell acquired 2,039 shares via RSU vesting and withheld 1,096 shares for tax obligations.

Guardant Health Chief Information Officer Kumud Kalia sold 3,418 shares of common stock on June 11, 2026.

Guardant Health Chief Information Officer Kumud Kalia sold 5,000 shares of common stock on June 10, 2026.

Co-Chief Executive Officer Helmy Eltoukhy sold 100,000 shares of Guardant Health common stock on June 5, 2026.

Guardant Health Chief Financial Officer Michael Brian Bell sold 2,000 shares of common stock on June 5, 2026.

Director Steve Krognes sold 9,294 shares of Guardant Health, Inc. common stock on June 4, 2026.

Director Meghan V. Joyce exercised stock options and sold 10,000 shares of Guardant Health, Inc. common stock.

Director Steve Krognes acquired 154 shares of Guardant Health common stock through the vesting of restricted stock units.

Director Manuel Hidalgo Medina sold 1,000 shares of Guardant Health, Inc. (GH) common stock on May 28, 2026.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., sold 10,000 shares of common stock on May 27, 2026.

Chris Freeman, Chief Commercial Officer at Guardant Health, Inc., reported the sale of 24,406 shares of common stock on May 22, 2026.

Guardant Health's Chief Legal Officer, John G. Saia, sold 19,000 shares of common stock in pre-planned transactions under a Rule 10b5-1 plan.

Guardant Health Co-Chief Executive Officer AmirAli Talasaz sold 210,000 shares of common stock for over $22.7 million through a pre-arranged 10b5-1 plan.

Guardant Health Director Ian T. Clark sold 6,876 shares of common stock for approximately $106.90 per share in a pre-planned transaction.

Guardant Health Director Manuel Hidalgo Medina exercised stock options and sold a portion of his common stock holdings.

Director Tariq Musa reported the vesting of restricted stock units and a subsequent sale of common stock in Guardant Health, Inc.

Director Manuel Hidalgo Medina acquired 232 shares of Guardant Health, Inc. common stock through the vesting of restricted stock units.

Guardant Health Chief Technology Officer Darya Chudova acquired 8,705 shares via RSU vesting, with 4,679 shares withheld for taxes.

Co-CEO AmirAli Talasaz sold 50,000 shares of Guardant Health common stock via a pre-arranged 10b5-1 trading plan.

Director Steve Krognes acquired 154 shares of Guardant Health common stock through the vesting of restricted stock units.

Director Roberto Mignone acquired 264 shares of Guardant Health common stock through the vesting of restricted stock units.

Director Manuel Hidalgo Medina acquired 232 shares of Guardant Health, Inc. common stock through the vesting of restricted stock units.